Literature DB >> 12056844

Inhibition of axon growth by oligodendrocyte precursor cells.

Zhi Jiang Chen1, Yvonne Ughrin, Joel M Levine.   

Abstract

The glial scar that forms at the site of injury is thought to be a biochemical and physical barrier to successful regeneration, although the molecules responsible for this barrier function are not well understood. Glia scars contain large numbers of oligodendrocyte precursor cells (OPCs) and these cells can produce several different growth-inhibitory chondroitin sulfate proteoglycans (CSPGs), including NG2, neurocan, and phosphacan. Here, we used membrane-based assays to show that the surface of OPCs is both nonpermissive and inhibitory for neurite outgrowth. Inhibition of growth by OPC is reversed by treatment with antibodies against the NG2 CSPG and the expression of NG2 is sufficient to change a growth-permissive cell surface to a nonpermissive surface. These result suggest that the OPCs that accumulate rapidly at sites of CNS injury can contribute to the creation of an environment that inhibits nerve regeneration and that NG2 is a necessary feature of that environment. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056844     DOI: 10.1006/mcne.2002.1102

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  25 in total

Review 1.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

2.  Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.

Authors:  Ellen M Andrews; Rebekah J Richards; Feng Q Yin; Mariano S Viapiano; Lyn B Jakeman
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

3.  Peripheral axons of the adult zebrafish maxillary barbel extensively remyelinate during sensory appendage regeneration.

Authors:  Alex C Moore; Tiffany E Mark; Ann K Hogan; Jacek Topczewski; Elizabeth E LeClair
Journal:  J Comp Neurol       Date:  2012-12-15       Impact factor: 3.215

Review 4.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

5.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

6.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

Review 7.  NG2: a component of the glial scar that inhibits axon growth.

Authors:  Andrew M Tan; Weibing Zhang; Joel M Levine
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

8.  Spatiotemporal distribution of chondroitin sulfate proteoglycans after optic nerve injury in rodents.

Authors:  Craig S Pearson; Andrea G Solano; Sharada M Tilve; Caitlin P Mencio; Keith R Martin; Herbert M Geller
Journal:  Exp Eye Res       Date:  2019-11-06       Impact factor: 3.467

9.  Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury.

Authors:  Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Alicia L Hawthorne; Lianhua Bai; Robert H Miller; Jerry Silver
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

Review 10.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.